IV ketamine for Deerfield Beach — psychiatry-supervised, integrated with therapy.

RECO Health's ketamine program is 13 miles up A1A from Deerfield Beach — a 22-minute drive that gives clients from The Cove, Pioneer Park, and Hillsboro Beach clinical separation without disrupting work or family. Every infusion is psychiatrist-supervised, monitored on continuous vitals and the CADSS, and paired with integration therapy the following day. We offer both IV racemic ketamine and Spravato and match the modality to the clinical picture and the insurance situation — not the other way around. Ketamine at RECO is never delivered as a standalone infusion service; it is embedded in a full psychiatric and psychotherapeutic treatment plan.

Deerfield Beach sits 13 miles south of RECO Health’s Delray campus — a 22-minute drive up A1A or I-95 depending on the hour. For residents of The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, and Goldcoast Centre, that distance is short enough to keep treatment woven into work and family life, but long enough to create real physical separation from the people and places that reinforce depression, trauma responses, or active use. RECO’s ketamine therapy program is psychiatry-supervised, integrated with therapy, and reserved for the clinical presentations where the evidence supports it.

Ketamine’s mechanism and why it works fast

Ketamine is a non-competitive NMDA receptor antagonist. Blocking NMDA channels drives a downstream cascade — AMPA receptor throughput increases, BDNF release rises, and synaptogenesis in the prefrontal cortex and hippocampus follows within hours. That last step matters clinically: chronic depression is associated with dendritic atrophy in exactly those regions, and rapid synaptogenesis is the biological signature most tightly tied to symptom relief.

The contrast with SSRIs is what makes ketamine distinct. Sertraline, escitalopram, and duloxetine act on monoamine reuptake, and clinical response takes four to six weeks — sometimes longer — because the mechanism sits upstream of the plasticity changes ketamine triggers directly. In a patient with treatment-resistant depression who has already failed two adequate SSRI trials, or in a patient with acute suicidality where six weeks is not a clinical option, that time-to-response gap is the entire argument for ketamine.

Ketamine is not a first-line antidepressant, and RECO does not use it that way. It sits in the pathway after adequate trials of SSRIs and SNRIs, after augmentation with lithium, aripiprazole, or quetiapine has been tried or ruled out, and after a competent course of psychotherapy has been offered.

The 40-minute infusion, monitored recovery, and six-session induction

Each infusion session at RECO runs roughly two hours end-to-end. Intake vitals are captured, an IV is placed, and 0.5 mg/kg of racemic ketamine is infused over 40 minutes on a programmable pump. Dose is weight-adjusted and, in later sessions, titrated based on response and tolerability of dissociation. During the infusion, blood pressure, heart rate, and pulse oximetry are monitored continuously by clinical staff. Dissociative symptoms are tracked with the Clinician-Administered Dissociative States Scale (CADSS), and depressive symptom trajectory is followed between sessions with the PHQ-9.

After the infusion, clients spend 30 to 60 minutes in a monitored recovery bay until vitals normalize and dissociation has fully resolved. Driving is prohibited for the remainder of the day — clients arrange transport or use rideshare, and the clinical team confirms that arrangement before the infusion starts.

The standard induction is six infusions delivered across two to three weeks. That interval is not arbitrary: the published trials establish it as the window where sustained response either consolidates or fails to. Maintenance boosters — typically single infusions at gradually increasing intervals — are scheduled based on response duration and ongoing PHQ-9 tracking.

Integration with psychotherapy makes response durable

Ketamine opens a window. Whether the client walks through it is determined by what happens in therapy the next day, the next week, and the next month. RECO’s protocol pairs the infusion series with integration sessions — typically scheduled the day after each infusion — where a licensed therapist works with the affective and cognitive material that surfaced during the session and consolidates the shifts into lasting change.

The therapeutic frame draws from CBT for cognitive restructuring around depressive rumination, ACT for values clarification and defusion from suicidal thinking, DBT skills for affect regulation between infusions, and, where trauma is a driver, EMDR or trauma-focused CBT. For patients with treatment-resistant depression and comorbid trauma — a common presentation — the integration work is where the treatment either produces durable remission or reverts to baseline within weeks.

The published literature on ketamine without integration shows shorter response duration and higher rates of early relapse. RECO does not offer standalone infusion services for that reason. Every ketamine client is enrolled in concurrent therapy, and the psychiatrist, therapist, and infusion nurse operate as a coordinated team through weekly case review.

Ketamine vs Spravato and how we decide

IV racemic ketamine is off-label for depression and, in nearly all cases, cash-pay. Spravato — intranasal esketamine — is FDA-approved for treatment-resistant depression and covered by most commercial insurance under a REMS protocol that mandates in-clinic administration and two hours of post-dose monitoring. Both are options at RECO, and the choice is made with the client during the psychiatry consult.

Insurance coverage is often the deciding factor. For clients with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, or BCBS coverage and documented failure of two antidepressant trials, Spravato is frequently the lower-cost route. The Spravato induction is twice weekly for four weeks, then weekly for four weeks, then every-other-week — a longer clinical footprint than the six-session IV induction, but with insurance offsetting most of the cost.

IV ketamine wins on dose flexibility, on response quality in a subset of patients who tolerate dissociation poorly at Spravato’s fixed doses, and on compressed timelines when clinical urgency argues for a two-week induction rather than eight. The psychiatrist frames the trade-off explicitly and the client decides.

What to expect on your first visit

The first visit is a psychiatric evaluation, not an infusion. A RECO psychiatrist takes a full history — prior antidepressant trials with dose and duration, response to any prior ketamine or ECT, current medications, cardiovascular history, and any history of psychosis or mania (both are contraindications). The PHQ-9, GAD-7, and Columbia Suicide Severity Rating Scale are administered; if trauma is a driver, a structured trauma screen is added.

If IV ketamine is clinically indicated, the treatment plan is written the same day: six-session induction schedule, integration therapy pairing, medication review (benzodiazepines and lamotrigine in particular can blunt ketamine’s effect and are addressed in advance), and cost or insurance discussion around Spravato as an alternative. The first infusion is typically scheduled within the following week.

Insurance and admissions from Deerfield Beach

RECO Health accepts Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS for the psychiatric evaluation, for concurrent therapy, and — where the client elects it — for Spravato. IV ketamine infusions are cash-pay in most cases, and the admissions team provides a written cost estimate before the first session is scheduled.

For clients driving from Deerfield Beach, the trip up A1A or I-95 to the Delray campus is 13 miles and averages 22 minutes outside rush hour. Sessions are scheduled with post-infusion transport in mind, and many Deerfield clients coordinate with a partner or family member for the drive home. Admissions can be reached directly to verify benefits before the first appointment.

Serving residents of: The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, Goldcoast Centre.